Send me real-time posts from this site at my email
Zacks

Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop

For Immediate Release

Chicago, IL – June 12, 2019 - Stocks in this week’s article are CDW Corp. CDW, Bristol-Myers Squibb Co. BMY, Celgene Corp. CELG, PepsiCo, Inc. PEP and Northrop Grumman Corp. NOC.

Top 5 ROE Stocks to Buy as U.S.-Mexico Trade Concerns Abate

The U.S. equity markets extended their recent bull run as the Trump administration dropped its plans to impose 5% tariff on all Mexican goods amid row over migration deal. With the Mexican government promising to step up measures in order to stem the flow of illegal immigrants to the United States, the markets received a shot in the arm as trade concerns between the two neighboring countries abated. However, the Sino-U.S. trade war continued to brew with no visible respite in the near term as both countries remained firm in their positions.

As investors employ a wait-and-see approach in a classic example of “backing and filling” in the market, they can benefit from ‘cash cow’ stocks that garner higher returns.

However, singling out cash-rich stocks alone does not make for a solid investment proposition unless these are backed by attractive efficiency ratios, like return on equity (ROE).  A high ROE ensures that the company is reinvesting its cash at a high rate of return.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/427831/top-5-roe-stocks-to-buy-as-usmexico-trade-concerns-abate?art_rec=quote-stock_overview-zacks_news-ID01-txt-427831

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter: 

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch">http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CDW Corporation (CDW): Free Stock Analysis Report
 
Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report
 
Northrop Grumman Corporation (NOC): Free Stock Analysis Report
 
Pepsico, Inc. (PEP): Free Stock Analysis Report
 
Celgene Corporation (CELG): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue